CN104788327B - 一种治疗呼吸系统疾病的盐酸氨溴索化合物及其制备方法 - Google Patents
一种治疗呼吸系统疾病的盐酸氨溴索化合物及其制备方法 Download PDFInfo
- Publication number
- CN104788327B CN104788327B CN201510245812.7A CN201510245812A CN104788327B CN 104788327 B CN104788327 B CN 104788327B CN 201510245812 A CN201510245812 A CN 201510245812A CN 104788327 B CN104788327 B CN 104788327B
- Authority
- CN
- China
- Prior art keywords
- ambroxol
- ambroxol hydrochloride
- compound
- preparation
- respiratory system
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- -1 ambroxol compound Chemical class 0.000 title claims abstract description 37
- 229960005174 ambroxol Drugs 0.000 title claims abstract description 34
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- 208000023504 respiratory system disease Diseases 0.000 title claims abstract description 8
- 239000003814 drug Substances 0.000 claims abstract description 11
- 230000005260 alpha ray Effects 0.000 claims abstract description 7
- 238000005259 measurement Methods 0.000 claims abstract description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 54
- 229960000985 ambroxol hydrochloride Drugs 0.000 claims description 44
- QNVKOSLOVOTXKF-UHFFFAOYSA-N 4-[(2-amino-3,5-dibromophenyl)methylamino]cyclohexan-1-ol;hydron;chloride Chemical compound Cl.NC1=C(Br)C=C(Br)C=C1CNC1CCC(O)CC1 QNVKOSLOVOTXKF-UHFFFAOYSA-N 0.000 claims description 41
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 30
- 239000000843 powder Substances 0.000 claims description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 17
- 239000012046 mixed solvent Substances 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 12
- 239000013078 crystal Substances 0.000 claims description 11
- 239000012065 filter cake Substances 0.000 claims description 10
- 238000010586 diagram Methods 0.000 claims description 7
- 229910017488 Cu K Inorganic materials 0.000 claims description 6
- 229910017541 Cu-K Inorganic materials 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 6
- 229940079593 drug Drugs 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 238000005406 washing Methods 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 5
- 239000000725 suspension Substances 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 1
- 229910052794 bromium Inorganic materials 0.000 claims 1
- 238000000634 powder X-ray diffraction Methods 0.000 abstract description 3
- 238000012360 testing method Methods 0.000 description 10
- 239000000243 solution Substances 0.000 description 9
- 239000007788 liquid Substances 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 230000028327 secretion Effects 0.000 description 4
- 206010036790 Productive cough Diseases 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 210000000214 mouth Anatomy 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 238000012552 review Methods 0.000 description 3
- 238000005070 sampling Methods 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 238000004088 simulation Methods 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- JBDGDEWWOUBZPM-XYPYZODXSA-N ambroxol Chemical compound NC1=C(Br)C=C(Br)C=C1CN[C@@H]1CC[C@@H](O)CC1 JBDGDEWWOUBZPM-XYPYZODXSA-N 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- 210000003097 mucus Anatomy 0.000 description 2
- 210000002345 respiratory system Anatomy 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- XBFISNPWDYRTRZ-UHFFFAOYSA-N N.Cl.[Br] Chemical class N.Cl.[Br] XBFISNPWDYRTRZ-UHFFFAOYSA-N 0.000 description 1
- 208000018569 Respiratory Tract disease Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000001886 ciliary effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 239000003580 lung surfactant Substances 0.000 description 1
- 239000008176 lyophilized powder Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 230000000510 mucolytic effect Effects 0.000 description 1
- 239000006191 orally-disintegrating tablet Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/10—Separation; Purification; Stabilisation; Use of additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (2)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610603811.XA CN106349088A (zh) | 2015-05-15 | 2015-05-15 | 一种制备治疗呼吸系统疾病的盐酸氨溴索化合物晶体的方法 |
CN201610604043.XA CN106220518A (zh) | 2015-05-15 | 2015-05-15 | 一种制备治疗呼吸系统疾病的盐酸氨溴索化合物晶体的方法 |
CN201610603812.4A CN106242983A (zh) | 2015-05-15 | 2015-05-15 | 一种制备治疗呼吸系统疾病的盐酸氨溴索化合物晶体的方法 |
CN201610603813.9A CN106242982A (zh) | 2015-05-15 | 2015-05-15 | 一种制备治疗呼吸系统疾病的盐酸氨溴索化合物晶体的方法 |
CN201510245812.7A CN104788327B (zh) | 2015-05-15 | 2015-05-15 | 一种治疗呼吸系统疾病的盐酸氨溴索化合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510245812.7A CN104788327B (zh) | 2015-05-15 | 2015-05-15 | 一种治疗呼吸系统疾病的盐酸氨溴索化合物及其制备方法 |
Related Child Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610604043.XA Division CN106220518A (zh) | 2015-05-15 | 2015-05-15 | 一种制备治疗呼吸系统疾病的盐酸氨溴索化合物晶体的方法 |
CN201610603813.9A Division CN106242982A (zh) | 2015-05-15 | 2015-05-15 | 一种制备治疗呼吸系统疾病的盐酸氨溴索化合物晶体的方法 |
CN201610603812.4A Division CN106242983A (zh) | 2015-05-15 | 2015-05-15 | 一种制备治疗呼吸系统疾病的盐酸氨溴索化合物晶体的方法 |
CN201610603811.XA Division CN106349088A (zh) | 2015-05-15 | 2015-05-15 | 一种制备治疗呼吸系统疾病的盐酸氨溴索化合物晶体的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104788327A CN104788327A (zh) | 2015-07-22 |
CN104788327B true CN104788327B (zh) | 2016-08-24 |
Family
ID=53553573
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610603811.XA Withdrawn CN106349088A (zh) | 2015-05-15 | 2015-05-15 | 一种制备治疗呼吸系统疾病的盐酸氨溴索化合物晶体的方法 |
CN201510245812.7A Expired - Fee Related CN104788327B (zh) | 2015-05-15 | 2015-05-15 | 一种治疗呼吸系统疾病的盐酸氨溴索化合物及其制备方法 |
CN201610604043.XA Withdrawn CN106220518A (zh) | 2015-05-15 | 2015-05-15 | 一种制备治疗呼吸系统疾病的盐酸氨溴索化合物晶体的方法 |
CN201610603813.9A Withdrawn CN106242982A (zh) | 2015-05-15 | 2015-05-15 | 一种制备治疗呼吸系统疾病的盐酸氨溴索化合物晶体的方法 |
CN201610603812.4A Withdrawn CN106242983A (zh) | 2015-05-15 | 2015-05-15 | 一种制备治疗呼吸系统疾病的盐酸氨溴索化合物晶体的方法 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610603811.XA Withdrawn CN106349088A (zh) | 2015-05-15 | 2015-05-15 | 一种制备治疗呼吸系统疾病的盐酸氨溴索化合物晶体的方法 |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610604043.XA Withdrawn CN106220518A (zh) | 2015-05-15 | 2015-05-15 | 一种制备治疗呼吸系统疾病的盐酸氨溴索化合物晶体的方法 |
CN201610603813.9A Withdrawn CN106242982A (zh) | 2015-05-15 | 2015-05-15 | 一种制备治疗呼吸系统疾病的盐酸氨溴索化合物晶体的方法 |
CN201610603812.4A Withdrawn CN106242983A (zh) | 2015-05-15 | 2015-05-15 | 一种制备治疗呼吸系统疾病的盐酸氨溴索化合物晶体的方法 |
Country Status (1)
Country | Link |
---|---|
CN (5) | CN106349088A (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104940155A (zh) * | 2015-08-04 | 2015-09-30 | 青岛蓝盛洋医药生物科技有限责任公司 | 一种治疗呼吸系统疾病的药物盐酸氨溴索组合物片剂 |
CN105078883A (zh) * | 2015-09-10 | 2015-11-25 | 青岛蓝盛洋医药生物科技有限责任公司 | 一种治疗呼吸系统疾病的药物盐酸氨溴索组合物水针剂 |
CN105078896A (zh) * | 2015-09-22 | 2015-11-25 | 青岛华之草医药科技有限公司 | 一种治疗咳嗽的药物盐酸氨溴索组合物干混悬剂 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1593579B1 (de) * | 1966-05-10 | 1972-02-03 | Thomae Gmbh Dr K | Hydroxy-cyclohexylamine,deren physiologisch vertraeglichen Saeureadditionssalze und Verfahren zu ihrer Herstellung |
CN1303065C (zh) * | 2004-05-20 | 2007-03-07 | 江苏豪森药业股份有限公司 | 氨溴索半胱氨酸类似物盐及其制备方法和用途 |
CN101337897B (zh) * | 2007-07-06 | 2012-02-29 | 江苏恒瑞医药股份有限公司 | 一种制备氨溴索及其类似物或其盐的方法 |
CN102153482B (zh) * | 2011-02-28 | 2013-04-03 | 天津市铭泰医药科技有限公司 | 注射级盐酸氨溴索的精制方法和产品及其注射液 |
CN102516096B (zh) * | 2011-11-28 | 2013-09-25 | 海南灵康制药有限公司 | 一种盐酸氨溴索化合物的精制法 |
CN102702001B (zh) * | 2012-07-06 | 2013-08-07 | 天津梅花医药有限公司 | 稳定的无定型盐酸氨溴索化合物 |
CN103012167A (zh) * | 2012-12-16 | 2013-04-03 | 石药集团中诺药业(石家庄)有限公司 | 一种盐酸氨溴索的制备方法 |
CN103073439B (zh) * | 2013-02-05 | 2013-10-16 | 山东罗欣药业股份有限公司 | 一种盐酸氨溴索化合物的合成方法 |
CN103073438B (zh) * | 2013-02-05 | 2013-08-14 | 山东罗欣药业股份有限公司 | 一种盐酸氨溴索化合物的精制方法 |
IN2013MU01217A (zh) * | 2013-03-28 | 2015-04-10 | Ami Lifesciences Pvt Ltd | |
CN103755577B (zh) * | 2014-01-17 | 2015-11-18 | 浙江浙邦制药有限公司 | 一种从盐酸氨溴索精制母液中回收氨溴索碱的方法 |
CN104193627B (zh) * | 2014-08-18 | 2016-05-25 | 江苏正大清江制药有限公司 | 一种氨溴索与3,4-二羟基苯甲酸药物共晶及其制备方法 |
-
2015
- 2015-05-15 CN CN201610603811.XA patent/CN106349088A/zh not_active Withdrawn
- 2015-05-15 CN CN201510245812.7A patent/CN104788327B/zh not_active Expired - Fee Related
- 2015-05-15 CN CN201610604043.XA patent/CN106220518A/zh not_active Withdrawn
- 2015-05-15 CN CN201610603813.9A patent/CN106242982A/zh not_active Withdrawn
- 2015-05-15 CN CN201610603812.4A patent/CN106242983A/zh not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
CN104788327A (zh) | 2015-07-22 |
CN106349088A (zh) | 2017-01-25 |
CN106242983A (zh) | 2016-12-21 |
CN106220518A (zh) | 2016-12-14 |
CN106242982A (zh) | 2016-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6612200B2 (ja) | 抗炎症性の置換シクロブテンジオン化合物のコリン塩 | |
CN104788327B (zh) | 一种治疗呼吸系统疾病的盐酸氨溴索化合物及其制备方法 | |
BRPI0620960A2 (pt) | formas sólidas de n-[2,4-bis(1,1-dimetiletil)-5-hidroxifenil]-1,4-didro-4- oxiquinolina-3- carboxamida | |
BR112020009634A2 (pt) | preparação farmacêutica que tem excelentes propriedades de fotoestabilização e dissolução | |
CN104860832B (zh) | 一种治疗呼吸系统疾病的药物盐酸氨溴索组合物 | |
BR112020018697A2 (pt) | Composição farmacêutica incluindo alquilsulfato de sódio | |
WO2015074524A1 (zh) | 卟啉铁固体分散体及其制备方法 | |
JP2021517162A (ja) | C−metキナーゼ阻害剤としての化合物の結晶及びその調製方法及びその使用 | |
CN104803860B (zh) | 一种盐酸氨溴索化合物及其药物组合物 | |
BR112020021059A2 (pt) | formulação sólida tendo excelente estabilidade | |
CN105055383A (zh) | 一种化痰药物盐酸氨溴索组合物 | |
WO2017032111A1 (zh) | 二羟基丙酮在制备抗肿瘤的药物中的用途 | |
CN111333555B (zh) | 一种s-(羧甲基)-l-半胱氨酸铵无水晶型、制备方法及其用途 | |
CN102908377B (zh) | 一种益肝灵分散片及其制备方法 | |
CN104829467A (zh) | 盐酸氨溴索二水化合物 | |
CN105055321A (zh) | 一种治疗咳嗽的药物盐酸氨溴索组合物干混悬剂 | |
BR122022006356B1 (pt) | Forma de dosagem sólida | |
CN104958317A (zh) | 一种祛痰药物盐酸氨溴索组合物 | |
CN105055384A (zh) | 一种治疗咳嗽的药物盐酸氨溴索组合物 | |
CN105078896A (zh) | 一种治疗咳嗽的药物盐酸氨溴索组合物干混悬剂 | |
CN105078883A (zh) | 一种治疗呼吸系统疾病的药物盐酸氨溴索组合物水针剂 | |
CN104971057A (zh) | 一种治疗呼吸系统疾病的药物盐酸氨溴索组合物胶囊 | |
CN104922079A (zh) | 一种祛痰的药物盐酸氨溴索冻干粉针剂组合物 | |
CN105078917A (zh) | 一种治疗呼吸系统疾病的药物盐酸氨溴索组合物片剂 | |
KR101823405B1 (ko) | 신규한 실로스타졸 염 화합물 및 이의 용도 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
EXSB | Decision made by sipo to initiate substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Fan Guangming Inventor after: Wang Xinyue Inventor before: Yu Xiangfen |
|
COR | Change of bibliographic data | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160725 Address after: 264000 Shandong Province, Yantai City Economic and Technological Development Zone Industry odd Road No. 2, Room 102 on the right side of the vertical snow garden Simon Applicant after: YANTAI LANYANGZHICAO PHARMACEUTICAL BIOTECHNOLOGY CO., LTD. Applicant after: Fan Guangming Applicant after: Wang Xinyue Address before: 276017, Linyi 25 high tech Industrial Development Zone, Di Di science and Technology Information Service Center, building No., Shandong Applicant before: Miao Yiwen |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Fan Guangming Inventor after: Wang Xinyue Inventor after: Yu Xiangfen Inventor after: Shen Xiang Inventor after: Peng Xueyang Inventor before: Fan Guangming Inventor before: Wang Xinyue |
|
COR | Change of bibliographic data | ||
TR01 | Transfer of patent right |
Effective date of registration: 20161014 Address after: 264000 Shandong Province, Yantai City Economic and Technological Development Zone Industry odd Road No. 2, Room 102 on the right side of the vertical snow garden Simon Patentee after: YANTAI LANYANGZHICAO PHARMACEUTICAL BIOTECHNOLOGY CO., LTD. Address before: 264000 Shandong Province, Yantai City Economic and Technological Development Zone Industry odd Road No. 2, Room 102 on the right side of the vertical snow garden Simon Patentee before: YANTAI LANYANGZHICAO PHARMACEUTICAL BIOTECHNOLOGY CO., LTD. Patentee before: Fan Guangming Patentee before: Wang Xinyue |
|
CB03 | Change of inventor or designer information |
Inventor after: Fan Guangming Inventor after: Wang Xinyue Inventor after: Yu Xiangfen Inventor after: Shen Xiang Inventor after: Peng Xueyang Inventor after: Li Gongyan Inventor after: Xu Qiwen Inventor before: Fan Guangming Inventor before: Wang Xinyue Inventor before: Yu Xiangfen Inventor before: Shen Xiang Inventor before: Peng Xueyang |
|
CB03 | Change of inventor or designer information | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170606 Address after: 10 village, four floor village, cooperative Town, Qidong City, Jiangsu, Nantong 226200 Patentee after: Nantong Kai Wunong Products Co. Ltd. Address before: 264000 Shandong Province, Yantai City Economic and Technological Development Zone Industry odd Road No. 2, Room 102 on the right side of the vertical snow garden Simon Patentee before: YANTAI LANYANGZHICAO PHARMACEUTICAL BIOTECHNOLOGY CO., LTD. |
|
TR01 | Transfer of patent right | ||
CB03 | Change of inventor or designer information |
Inventor after: Fan Guangming Inventor after: Wang Xinyue Inventor after: Yu Xiangfen Inventor after: Shen Xiang Inventor after: Peng Xueyang Inventor after: Li Gongyan Inventor after: Xu Qiwen Inventor after: Zhang Jirong Inventor after: Yao Fangcheng Inventor before: Fan Guangming Inventor before: Wang Xinyue Inventor before: Yu Xiangfen Inventor before: Shen Xiang Inventor before: Peng Xueyang Inventor before: Li Gongyan Inventor before: Xu Qiwen |
|
CB03 | Change of inventor or designer information | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160824 Termination date: 20190515 |
|
CF01 | Termination of patent right due to non-payment of annual fee |